Rudy Dekeyser

Biography

Dr. Rudy Dekeyser is Non-Executive Director of Curetis BV. He joined LSP in 2012 to become managing partner of LSP's Health Economics Fund. His prime focus and responsibility within LSP is to invest in unlisted securities. Prior to joining LSP, Dr. Dekeyser was Managing Director of VIB (1995 to 2012), the Flanders Institute for Biotechnology, which he helped establish in 1995. Under his leadership, the institute has grown to become one of Europe's most successful incubators in the area of life sciences. Over the years, Dr. Dekeyser has been appointed as Director of many companies and has been a senior Advisor to a number of investment firms. Dr. Dekeyser served on the supervisory board of many companies, including Ablynx NV (2001 to 2007), CropDesign (1998 to 2006), Pronota NV (2004 to 2012), ActoGeniX NV (2006 to 2012) and Multiplicom NV (2010 to 2012). He currently serves as a member of the supervisory board of Sequana Medical AG (since 2014), Celyad SA (since 2005), reMYND NV (since 2009) and EMBLEM GmbH (since 2001). Since November 2014, he has been a member of the supervisory board at Curetis AG. Dr. Dekeyser is a Co-Founding Board Member of the European Association of Science and Technology Transfer Professionals (ASTP). Dr. Dekeyser has a Master's degree in Zoology and a Ph.D. in Molecular Biology from the Ghent University and is chairman/member of many international advisory boards on innovation in life sciences. He is Member of the Audit and Remuneration Committees of the Company.

Research Interest

  Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management